These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 20965219)

  • 1. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
    Acharya S; Sahoo SK
    Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLGA/polymeric liposome for targeted drug and gene co-delivery.
    Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
    Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.
    Maruyama K
    Adv Drug Deliv Rev; 2011 Mar; 63(3):161-9. PubMed ID: 20869415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor delivery of macromolecular drugs based on the EPR effect.
    Torchilin V
    Adv Drug Deliv Rev; 2011 Mar; 63(3):131-5. PubMed ID: 20304019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K; Erfan M; Dadashzadeh S
    Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma.
    Hatakeyama H; Akita H; Harashima H
    Adv Drug Deliv Rev; 2011 Mar; 63(3):152-60. PubMed ID: 20840859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy.
    Maeda H; Matsumura Y
    Adv Drug Deliv Rev; 2011 Mar; 63(3):129-30. PubMed ID: 20457195
    [No Abstract]   [Full Text] [Related]  

  • 9. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin.
    Lee H; Ahn CH; Park TG
    Macromol Biosci; 2009 Apr; 9(4):336-42. PubMed ID: 19006195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo.
    Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
    Colloids Surf B Biointerfaces; 2012 Apr; 92():50-4. PubMed ID: 22154100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA-based nanoparticles: effect of chitosan in the aggregate stabilization. A dielectric relaxation spectroscopy study.
    Chronopoulou L; Cutonilli A; Cametti C; Dentini M; Palocci C
    Colloids Surf B Biointerfaces; 2012 Sep; 97():117-23. PubMed ID: 22609591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
    Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
    J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
    Saxena V; Sadoqi M; Shao J
    Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
    Sankar R; Ravikumar V
    Biomed Pharmacother; 2014 Sep; 68(7):865-71. PubMed ID: 25107842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA-based nanoparticles as cancer drug delivery systems.
    Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
    Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
    Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
    Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents.
    Manchanda R; Fernandez-Fernandez A; Nagesetti A; McGoron AJ
    Colloids Surf B Biointerfaces; 2010 Jan; 75(1):260-7. PubMed ID: 19775872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
    McCarron PA; Marouf WM; Donnelly RF; Scott C
    J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.